Latham BioPharm Group is thrilled to announce the addition of three new team members

LBG is thrilled to announce the addition of Dr. Robert Casillas, Dr. Thijs Beuming and Dr. Darrel J. Rezac to our Team—each of whom brings unique expertise that widens the portfolio of services we are able to offer to our clients.

Robert P. Casillas, Ph.D., Fellow ATS 
Director, specializing in Nonclinical Consulting

Thijs Beuming, Ph.D.
Principal Consultant, specializing in In Silico Drug Discovery

Darrel J. Rezac, Ph.D.
Consultant, specializing in Nonclinical Animal Health

LBG recognizes the need for experienced consulting services in the ever-changing landscape of Life Sciences product development. We are constantly engaging new talent and experts in areas where there is high demand.

You may read more about each of our Team members and the value they bring to our clients here.